Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
Abstract Randomized controlled trials (RCTs) are regarded as the most reputable source of evidence. In some studies, factors beyond the intervention itself may contribute to the measured effect, an occurrence known as heterogeneity of treatment effect (HTE). If the RCT population differs from the re...
Main Authors: | Amelia J. Averitt, Chunhua Weng, Patrick Ryan, Adler Perotte |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-05-01
|
Series: | npj Digital Medicine |
Online Access: | https://doi.org/10.1038/s41746-020-0277-8 |
Similar Items
-
Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort
by: Dirk von Lewinski, et al.
Published: (2023-11-01) -
Machine learning enabled subgroup analysis with real-world data to inform clinical trial eligibility criteria design
by: Jie Xu, et al.
Published: (2023-01-01) -
P847: How clinical trial-inclusion criteria are failing phenylketonuria patients and risking exhaustion of the eligible patient population.
by: Claire Oliver, et al.
Published: (2024-01-01) -
Medical eligibility criteria for contraceptive use
by: Ma. del Carmen Cravioto Galindo
Published: (2016-01-01) -
Eligibility of real-world patients with metastatic breast cancer for clinical trials
by: Atul Batra, et al.
Published: (2020-12-01)